MILAN & MORRISTOWN, N.J.--(BUSINESS WIRE)---- $NWRN #Biotech--Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system (CNS), today announced that Stefan Weber, CEO and Roberto Galli, CFO, will participate in the following investor conferences in June: Jefferies Global Healthcare Conference, June 2–4, 2026, New York H.C. Wainwright 7th Annual